AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21653207 — intervention group
Group type: EXPERIMENTAL
Intervention: Short mesial resection (2.5 cm, n=34)
Number of subjects: 67
Study 21653207 — intervention group
Group type: EXPERIMENTAL
Intervention: Long mesial resection (3.5 cm, n=33)
Number of subjects: 67
Study 21653207 — intervention group
Group type: EXPERIMENTAL
Intervention: Resected hippocampal volume (larger left hippocampal volumes)
Number of subjects: 67
Study 21653207 — intervention group
Group type: EXPERIMENTAL
Intervention: Resected hippocampal volume (larger volumes on either side)
Number of subjects: 67
Study 18089661 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation programme provided by a trained clinical psychologist (n=70)
Number of subjects: 140
Study 18089661 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=70)
Number of subjects: 140
Study 17179643 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program for supervisors (24 supervisors), single-session, 60-min duration.
Number of subjects: 301
Study 17179643 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group (22 supervisors), no education program.
Number of subjects: 301
Study 14525823 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightwand intubation (n = 41)
Number of subjects: 80
Study 14525823 — intervention group
Group type: COMPARATOR
Intervention: Direct-vision laryngoscopy (n = 39)
Number of subjects: 80
Study 11097156 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisense oligodeoxynucleotides at 200, 400, and 800 micromol/L
Number of subjects: 10
Study 11097156 — intervention group
Group type: COMPARATOR
Intervention: Sense oligodeoxynucleotides at 100, 200, 400, and 800 micromol/L
Number of subjects: 10
Study 8651671 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuously warmed i.v. fluids (37.0 degrees C)
Number of subjects: 2
Study 8651671 — intervention group
Group type: COMPARATOR
Intervention: Prewarmed i.v. fluids that cooled to room temperature
Number of subjects: 2
Study 1352049 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia diagnostic classification
Number of subjects: 326
Study 1352049 — intervention group
Group type: COMPARATOR
Intervention: Other diagnostic classifications
Number of subjects: 326
Study 1352049 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological test performance
Number of subjects: 326
Study 1352049 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent mental state abnormalities
Number of subjects: 326
Study 6730937 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous delivery
Number of subjects: 46
Study 6730937 — intervention group
Group type: COMPARATOR
Intervention: Forceps delivery
Number of subjects: 46
Study 29853559 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol cigarette ban compliance
Number of subjects: 90
Study 29853559 — intervention group
Group type: COMPARATOR
Intervention: Gas stations
Number of subjects: 90
Study 30512083 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 0
Study 30512083 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed arthroscopic partial meniscectomy
Number of subjects: 0
Study 30512083 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 0
Study 27217310 — intervention group
Group type: EXPERIMENTAL
Intervention: SPF implementation in intervention group
Number of subjects: 25
Study 27217310 — intervention group
Group type: COMPARATOR
Intervention: Matched comparison group
Number of subjects: 25
Study 26678391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological REM sleep deprivation (clonidine)
Number of subjects: 26
Study 26678391 — intervention group
Group type: COMPARATOR
Intervention: Inert control pill
Number of subjects: 26
Study 23240877 — intervention group
Group type: EXPERIMENTAL
Intervention: NovaMin(®) paste (NM) followed by Nd:YAG laser irradiation at 1W (group B)
Number of subjects: 49
Study 23240877 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation at 1W (group G)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: NovaMin(®) paste (NM)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group A)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group C)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 1W (group D)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: NovaMin(®) paste (NM) (group E)
Number of subjects: 49
Study 23240877 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group F)
Number of subjects: 49
Study 21501001 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate
Number of subjects: 66
Study 18436116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 3852
Study 18436116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin plus GPI
Number of subjects: 3852
Study 18436116 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 3852
Study 16470361 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 16470361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14675269 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole treatment for 4 weeks
Number of subjects: 19
Study 14675269 — intervention group
Group type: COMPARATOR
Intervention: Control group (dyspepsia-free controls)
Number of subjects: 19
Study 10789600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse pressure
Number of subjects: 840
Study 10789600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean pressure
Number of subjects: 840
Study 9366737 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise programme of strength and balance retraining exercises
Number of subjects: 233
Study 9366737 — intervention group
Group type: COMPARATOR
Intervention: Usual care and social visits (control group)
Number of subjects: 233
Study 7877128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive psychotherapy (10 sessions of 50 min duration)
Number of subjects: 100
Study 7877128 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 100
Study 3170995 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT) with birch extract
Number of subjects: 40
Study 3170995 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IT)
Number of subjects: 40
Study 3170995 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 30648520 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 32
Study 30648520 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study 28921523 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth mindset intervention (30-min, computer-guided)
Number of subjects: 96
Study 28921523 — intervention group
Group type: COMPARATOR
Intervention: Supportive-therapy control
Number of subjects: 96
Study 26895983 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus contact (interactive session with a young person with lived experience of mental illness)
Number of subjects: 769
Study 26895983 — intervention group
Group type: COMPARATOR
Intervention: Education alone (1-day educational programme led by mental health professional staff)
Number of subjects: 769
Study 25809095 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure ulcer (PU) prevention bundle
Number of subjects: 140
Study 25809095 — intervention group
Group type: COMPARATOR
Intervention: Standard skin care as per local ICU policies (Control)
Number of subjects: 140
Study 22520085 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 160
Study 22520085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 20100966 — intervention group
Group type: EXPERIMENTAL
Intervention: cetuximab/TC
Number of subjects: 676
Study 20100966 — intervention group
Group type: COMPARATOR
Intervention: TC
Number of subjects: 676
Study 18842777 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole almond seed macroparticles (WA)
Number of subjects: 20
Study 18842777 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond oil (AO)
Number of subjects: 20
Study 18842777 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil blend (CO)
Number of subjects: 20
Study 16019088 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN protocol (70 degree tilt, 35 min, CSM at 5 min, 400 microg of glyceryl trinitrate spray administered sublingually at 20 min)
Number of subjects: 214
Study 16019088 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine protocol (70 degree tilt, 5 min, CSM when blood pressure is stable, adenosine bonus at 150 microg/kg after CSM)
Number of subjects: 214
Study 16019088 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-free protocol (70 degree tilt, 45 min, CSM at 5 and 45 min)
Number of subjects: 214
Study 16019088 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocols
Number of subjects: 214
Study 16019088 — intervention group
Group type: COMPARATOR
Intervention: Conventional management or ILR implantation (for patients without a definite indication for immediate cardiac pacing)
Number of subjects: 214
Study 12269767 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine cancer screening (mammograms and Pap tests)
Number of subjects: 0
Study 10566612 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 5156
Study 10566612 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy
Number of subjects: 5156
Study 10566612 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel + carboplatin
Number of subjects: 5156
Study 10566612 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 5156
Study 10566612 — intervention group
Group type: COMPARATOR
Intervention: Single agents (platinum analog or vinorelbine)
Number of subjects: 5156
Study 8807070 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 50 mg
Number of subjects: 39
Study 8807070 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 100 mg
Number of subjects: 39
Study 8807070 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 200 mg
Number of subjects: 39
Study 8807070 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin (all doses)
Number of subjects: 39
Study 1391670 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (4,800 mg/d for three months)
Number of subjects: 130
Study 1391670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 3890789 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin sulfate plus ticarcillin disodium (TT)
Number of subjects: 220
Study 3890789 — intervention group
Group type: COMPARATOR
Intervention: Moxalactam plus ticarcillin disodium (MT)
Number of subjects: 220
Study 30578103 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative arm
Number of subjects: 688
Study 30578103 — intervention group
Group type: COMPARATOR
Intervention: Verbal arm
Number of subjects: 688
Study 29056498 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 133
Study 29056498 — intervention group
Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 133
Study 29056498 — intervention group
Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 133
Study 26826975 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Bias Internalization Scale (WBIS)
Number of subjects: 90
Study 24663481 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene mesh (group A)
Number of subjects: 160
Study 24663481 — intervention group
Group type: COMPARATOR
Intervention: Standard abdominal wall closure (group B)
Number of subjects: 160
Study 22134512 — intervention group
Group type: EXPERIMENTAL
Intervention: Late course accelerated hyperfractionated radiotherapy (LCAF)
Number of subjects: 200
Study 22134512 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated radiotherapy (CF)
Number of subjects: 200
Study 20493532 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation with imipramine treatment
Number of subjects: 60
Study 20493532 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation with imipramine treatment
Number of subjects: 60
Study 20493532 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine treatment (with or without zinc supplementation)
Number of subjects: 60
Study 20493532 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine treatment (with zinc supplementation)
Number of subjects: 60
Study 18064443 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity, individualized (HI) treadmill training group
Number of subjects: 30
Study 18064443 — intervention group
Group type: COMPARATOR
Intervention: Lower‐intensity, generalized (LG) treadmill training group
Number of subjects: 30
Study 18064443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 16134043 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive behavior problems with deviant peer affiliation or low parental monitoring
Number of subjects: 582
Study 16134043 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive behavior problems with co-occurring depressive symptoms
Number of subjects: 582
Study 12236844 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg moxonidine alone
Number of subjects: 6
Study 12236844 — intervention group
Group type: COMPARATOR
Intervention: 400 mg quinidine sulphate with 0.2 mg moxonidine
Number of subjects: 6
Study 10416909 — intervention group
Group type: EXPERIMENTAL
Intervention: Passing a daily screen of weaning parameters
Number of subjects: 300
Study 9419612 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml iohexol
Number of subjects: 99
Study 9419612 — intervention group
Group type: COMPARATOR
Intervention: 40 ml ioxaglate
Number of subjects: 99
Study 1376721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-reversal electroretinograms (ERGs)
Number of subjects: 20
Study 1376721 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-reversal ERG acuity ratings
Number of subjects: 20
Study 4030190 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual weight training program
Number of subjects: 0
Study 4030190 — intervention group
Group type: EXPERIMENTAL
Intervention: Team training program
Number of subjects: 0
Study 4030190 — intervention group
Group type: COMPARATOR
Intervention: Soccer training alone (Control)
Number of subjects: 0
Study 31093764 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (50 min of treadmill walking at 5.0 km/h before the evening meal)
Number of subjects: 80
Study 31093764 — intervention group
Group type: COMPARATOR
Intervention: Control (50 min of sitting)
Number of subjects: 80
Study 31093764 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (50 min of treadmill walking)
Number of subjects: 80
Study 29471381 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab (VDZ/VDZ)
Number of subjects: 461
Study 29471381 — intervention group
Group type: COMPARATOR
Intervention: Placebo (VDZ/PBO)
Number of subjects: 461
Study 29471381 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior failure of antibiotic therapy
Number of subjects: 461
Study 26983548 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (5-15 mg/day)
Number of subjects: 100
Study 26983548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25248944 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led titration (NLT) clinic
Number of subjects: 28
Study 25248944 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 28
Study 22304745 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic ball attachments (20 subjects)
Number of subjects: 40
Study 22304745 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium ball attachments (20 subjects)
Number of subjects: 40
Study 20919481 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise program (duration: 18 to 22 weeks)
Number of subjects: 22
Study 20919481 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 22
Study 18036357 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified glucose-insulin-potassium (GIK) regimen (insulin 2.5 U/hour, dextrose and potassium titrated to prevent hyperglycemia)
Number of subjects: 32
Study 18036357 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution and potassium (controls)
Number of subjects: 32
Study 18036357 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified glucose-insulin-potassium (GIK) regimen
Number of subjects: 32
Study 16275185 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SESs)
Number of subjects: 74
Study 16275185 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMSs)
Number of subjects: 74
Study 11898063 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/d of alendronate for 10 weeks (A)
Number of subjects: 66
Study 11898063 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d of alendronate for 5 weeks (B)
Number of subjects: 66
Study 11898063 — intervention group
Group type: COMPARATOR
Intervention: No treatment (C)
Number of subjects: 66
Study 10473875 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 0
Study 10473875 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 0
Study 10473875 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 0
Study 7485937 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Epidural Analgesia (PCEA)
Number of subjects: 167
Study 7485937 — intervention group
Group type: COMPARATOR
Intervention: Midwife-Administered Intermittent Bolus (IB) Epidural Analgesia
Number of subjects: 167
Study 2097716 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin or netilmicin given by once daily or thrice daily injections
Number of subjects: 60
Study 2097716 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated creatinine clearance
Number of subjects: 60
Study 2097716 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional monitoring of aminoglycoside treatment
Number of subjects: 60
Study 421548 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nicotine cigarette (2.6 mg nicotine, 4.5 vol percent CO)
Number of subjects: 10
Study 421548 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-nicotine cigarette (0.1 mg nicotine, 1.1 vol percent CO)
Number of subjects: 10
Study 421548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigar (not inhaled)
Number of subjects: 10
Study 421548 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nicotine cigarette after beta blocker
Number of subjects: 10
Study 421548 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of CO
Number of subjects: 10
Study 30856095 — intervention group
Group type: EXPERIMENTAL
Intervention: Customary cosmetic usage score
Number of subjects: 2072
Study 27228145 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 83
Study 27228145 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 83
Study 25783757 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 208
Study 25783757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 23452521 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-second methylprednisolone injection
Number of subjects: 25
Study 23452521 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-second methylprednisolone injection
Number of subjects: 25
Study 20980399 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 1410
Study 20980399 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 1410
Study 20980399 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine physical check-ups (out-of-pocket)
Number of subjects: 1410
Study 20980399 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage at diagnosis of lung cancer
Number of subjects: 1410
Study 20980399 — intervention group
Group type: COMPARATOR
Intervention: Betel-nut consumption
Number of subjects: 1410
Study 19474132 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk (600 mL; 25 g protein, 36 g lactose, <1 g fat; 1062 kJ)
Number of subjects: 34
Study 19474132 — intervention group
Group type: COMPARATOR
Intervention: Fruit drink (600 mL; <1 g protein, 63 g sugar, <1 g fat; approximately 1062 kJ)
Number of subjects: 34
Study 19474132 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 34
Study 19474132 — intervention group
Group type: COMPARATOR
Intervention: Fruit drink
Number of subjects: 34
Study 17983369 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil 10 mg
Number of subjects: 501
Study 17983369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 14975536 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive rapid troponin I assay
Number of subjects: 4447
Study 14975536 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative rapid troponin I assay
Number of subjects: 4447
Study 14975536 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T elevation (>0.1 microg/l)
Number of subjects: 4447
Study 14975536 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin T results (>0.1 vs. < or =0.1 microg/l)
Number of subjects: 4447
Study 11581544 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based walking exercise program with structured coaching
Number of subjects: 31
Study 9039853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (O3) exposure at 0.24 ppm for 4 hours
Number of subjects: 19
Study 9039853 — intervention group
Group type: COMPARATOR
Intervention: Control (clean air) exposure for 4 hours
Number of subjects: 19
Study 9039853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (O3) exposure for 4 hours
Number of subjects: 19
Study 7950335 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5g imipenem infusion
Number of subjects: 10
Study 7950335 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g imipenem infusion
Number of subjects: 10
Study 3652464 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0